Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-05-11 Sale |
2020-05-13 4:18 pm |
Mirati Therapeutics Inc. | MRTX | CHEN ISAN EVP, Chief Medical Officer |
33,334 | $105 | $3,500,070 | 62,821 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Tyra Biosciences Inc. | TYRA | CHEN ISAN Director |
14,500 | $0 | 14,500 (Direct) |
View |
2022-06-13 Option Award |
2022-06-15 4:40 pm |
N/A 2032-06-12 |
Tyra Biosciences Inc. | TYRA | CHEN ISAN Director |
14,500 | $0 | 14,500 (Direct) |
View |
2021-09-17 Conversion |
2021-09-17 4:42 pm |
N/A N/A |
Tyra Biosciences Inc. | TYRA | CHEN ISAN Director |
85,100 | $0 | 192,783 (Direct) |
View |
Ownership |
2021-09-14 9:20 pm |
N/A N/A |
Tyra Biosciences Inc. | TYRA | CHEN ISAN Director |
0 | $0 | 260,250 (Direct) |
View |
2020-05-11 Exercise |
2020-05-13 4:18 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | CHEN ISAN EVP, Chief Medical Officer |
33,334 | $24.99 | 62,821 (Direct) |
View |
2020-05-11 Exercise |
2020-05-13 4:18 pm |
N/A 2026-01-21 |
Mirati Therapeutics Inc. | MRTX | CHEN ISAN EVP, Chief Medical Officer |
33,334 | $0 | 62,821 (Direct) |
View |